Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jun Wang, Baocheng Wang, Jing-Wang Bi, Kainan Li, J. Di (2012)
MDR1 gene C3435T polymorphism and cancer risk: a meta-analysis of 34 case–control studiesJournal of Cancer Research and Clinical Oncology, 138
T. Mizutani, A. Hattori (2005)
New Horizon of MDR1 (P-glycoprotein) StudyDrug Metabolism Reviews, 37
H. Gurney, H. Gurney, M. Wong, M. Wong, M. Wong, R. Balleine, R. Balleine, R. Balleine, L. Rivory, A. McLachlan, J. Hoskins, N. Wilcken, N. Wilcken, Christine Clarke, Christine Clarke, Christine Clarke, Graham Mann, Graham Mann, M. Collins, Delforce Se, K. Lynch, H. Schran (2007)
Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) GenotypeClinical Pharmacology & Therapeutics, 82
D. Koo, M. Ryu, B. Ryoo, M. Beck, Y. Na, Jae-Gook Shin, Sang Lee, Eun-Young Kim, Yoon-Koo Kang (2014)
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumorCancer Chemotherapy and Pharmacology, 75
M. Raymond, P. Gros (1989)
Mammalian multidrug-resistance gene: correlation of exon organization with structural domains and duplication of an ancestral gene.Proceedings of the National Academy of Sciences of the United States of America, 86 17
S. Marsh, J. Paul, Cristi King, G. Gifford, H. McLeod, Robert Brown (2007)
Pharmacogenetic assessment of toxicity and outcome after platinum plus taxane chemotherapy in ovarian cancer: the Scottish Randomised Trial in Ovarian Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 29
K. Shokat, A. Nackley, S. Shabalina, I. Tchivileva, K. Satterfield, O. Korchynskyi, S. Makarov, W. Maixner, A. Hoof, Kathryn O’Donnell, A. Guerrerio, Roy Parker, Stephen Miller, Mark Lunzer (2006)
Human Catechol-O-Methyltransferase Haplotypes Modulate Protein Expression by Altering mRNA Secondary StructureScience, 314
M. Schaefer, I. Roots, T. Gerloff (2006)
In-vitro transport characteristics discriminate wild-type ABCB1 (MDR1) from ALA893SER and ALA893THR polymorphismsPharmacogenetics and Genomics, 16
X. Declèves, S. Chevillard, Charlotte Charpentier, P. Vielh, J. Laplanche (2000)
A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P‐glycoproteinHuman Mutation, 15
N. Kartner, N. Kartner, J. Riordan, V. Ling, V. Ling (1983)
Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.Science, 221 4617
S.-F. Zhou (2008)
Structure, function and regulation of P-glycoprotein and its clinical relevance in drug dispositionXenobiotica, 38
(2008)
Following translation by single ribosomes one codon at a timeNature, 452
Z. Sauna, In-Wha Kim, K. Nandigama, S. Kopp, P. Chiba, S. Ambudkar (2007)
Catalytic cycle of ATP hydrolysis by P-glycoprotein: evidence for formation of the E.S reaction intermediate with ATP-gamma-S, a nonhydrolyzable analogue of ATP.Biochemistry, 46 48
C. Pauli-Magnus, J. Feiner, C. Brett, E. Lin, D. Kroetz (2003)
No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effectsClinical Pharmacology & Therapeutics, 74
T. Ikemura (1985)
Codon usage and tRNA content in unicellular and multicellular organisms.Molecular biology and evolution, 2 1
I. Macphee, S. Fredericks, Tracy Tai, P. Syrris, N. Carter, A. Johnston, L. Goldberg, D. Holt (2002)
Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and p-glycoprotein correlate with dose requirementTransplantation, 74
R. Juliano, V. Ling, V. Ling (1976)
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.Biochimica et biophysica acta, 455 1
Clive Onnie, S. Fisher, Reenal Pattni, J. Sanderson, A. Forbes, C. Lewis, C. Mathew (2006)
Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and Inflammatory Bowel Disease and their effects on disease behavior: A case‐control and meta‐analysis studyInflammatory Bowel Diseases, 12
F. Thiébaut, T. Tsuruo, H. Hamada, M. Gottesman, I. Pastan, M. Willingham (1987)
Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.Proceedings of the National Academy of Sciences of the United States of America, 84 21
C. Kimchi-Sarfaty, J. Gribar, M. Gottesman (2002)
Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression system.Molecular pharmacology, 62 1
M. Ameyaw, Fernando Regateiro, Tao Li, Xiehe Liu, Mohammed Tariq, A. Mobarek, Nadia Thornton, Gbolahan Folayan, Jessie Githang'a, A. Indalo, David Ofori-Adjei, David Price-Evans, Howard McLeod (2001)
MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.Pharmacogenetics, 11 3
Yi Chen, L. Mickley, Arnold Schwartz, E. Acton, Jaulang Hwang, A. Fojo (1990)
Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.The Journal of biological chemistry, 265 17
S. Wolf, Maulana Bachtiar, Jingbo Wang, T. Sim, Samuel Chong, Caroline Lee (2011)
An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokineticsThe Pharmacogenomics Journal, 11
C. Hrycyna, M. Ramachandra, S. Ambudkar, Y. Ko, P. Pedersen, I. Pastan, M. Gottesman (1998)
Mechanism of Action of Human P-glycoprotein ATPase ActivityThe Journal of Biological Chemistry, 273
Bei-bei Zhang, Chao Xuan, Kai-Feng Deng, N. Wu, Limin Lun (2013)
Association between the MDR1 gene variant C3435T and risk of leukaemia: a meta-analysis.European journal of cancer care, 22 5
I. Cascorbi, T. Gerloff, A. Johne, C. Meisel, S. Hoffmeyer, M. Schwab, E. Schaeffeler, M. Eichelbaum, Ulrich Brinkmann, I. Roots (2001)
Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjectsClinical Pharmacology & Therapeutics, 69
S. Bailey, A. Hinz, R. Kassen (2014)
Adaptive synonymous mutations in an experimentally evolved Pseudomonas fluorescens populationNature Communications, 5
T. He, Anwei Mo, Kai Zhang, Li Liu (2013)
ABCB1/MDR1 gene polymorphism and colorectal cancer risk: a meta‐analysis of case–control studiesColorectal Disease, 15
D. Hirt, F. Mentré, A. Tran, E. Rey, Solange Auleley, D. Salmon, X. Duval, J. Treluyer (2008)
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.British journal of clinical pharmacology, 65 4
R. Dawson, K. Locher (2006)
Structure of a bacterial multidrug ABC transporterNature, 443
Dandan Wu, Jixiang Zhang, Jiao Li, W. Dong (2014)
Lack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: a systemic review and meta-analysis.Asian Pacific journal of cancer prevention : APJCP, 15 7
Michał Dudarewicz, M. Barańska, Mariola Rychlik-Sych, R. Trzciński, A. Dziki, J. Skrętkowicz (2012)
C3435T Polymorphism of the ABCB1/MDR1 gene encoding P-glycoprotein in patients with inflammatory bowel disease in a Polish populationPharmacological Reports, 64
Jun Lee, Rongrong Wang, Yuan Yang, Xiaoyang Lu, Xing-guo Zhang, Linrun Wang, Y. Lou (2015)
The Effect of ABCB1 C3435T Polymorphism on Cyclosporine Dose Requirements in Kidney Transplant Recipients: A Meta‐AnalysisBasic & Clinical Pharmacology & Toxicology, 117
K. Mealey, S. Bentjen, J. Gay, G. Cantor (2001)
Ivermectin sensitivity in collies is associated with a deletion mutation of the mdr1 gene.Pharmacogenetics, 11 8
Bailing Zu, Yajuan Li, Xin Wang, D. He, Zheng-lan Huang, W. Feng (2014)
MDR1 gene polymorphisms and imatinib response in chronic myeloid leukemia: a meta-analysis.Pharmacogenomics, 15 5
S. Ambudkar, In-Wha Kim, Z. Sauna (2006)
The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 27 5
In-Wha Kim, Xiang-Hong Peng, Z. Sauna, P. FitzGerald, D. Xia, M. Müller, K. Nandigama, S. Ambudkar (2006)
The conserved tyrosine residues 401 and 1044 in ATP sites of human P-glycoprotein are critical for ATP binding and hydrolysis: evidence for a conserved subdomain, the A-loop in the ATP-binding cassette.Biochemistry, 45 24
J. Meletiadis, S. Chanock, T. Walsh (2006)
Human Pharmacogenomic Variations and Their Implications for Antifungal EfficacyClinical Microbiology Reviews, 19
I. Pastan, M. Gottesman, K. Ueda, E. Lovelace, Angelina Rutherford, M. Willingham (1988)
A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells.Proceedings of the National Academy of Sciences of the United States of America, 85 12
C. Anfinsen (1973)
Principles that govern the folding of protein chains.Science, 181 4096
E. Chufán, Hong‐May Sim, S. Ambudkar (2015)
Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies.Advances in cancer research, 125
Rafał Bartoszewski, M. Jablonský, Sylwia Bartoszewska, L. Stevenson, Q. Dai, J. Kappes, J. Collawn, Z. Bebok (2010)
A Synonymous Single Nucleotide Polymorphism in ΔF508 CFTR Alters the Secondary Structure of the mRNA and the Expression of the Mutant Protein*The Journal of Biological Chemistry, 285
Chrysoula Doxani, M. Voulgarelis, E. Zintzaras (2013)
MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysisBiomarkers, 18
P. Peethambaram, B. Fridley, R. Vierkant, M. Larson, K. Kalli, E. Elliott, A. Oberg, Kristin White, David Rider, G. Keeney, J. Cunningham, L. Hartmann, E. Goode (2011)
Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome.International journal of molecular epidemiology and genetics, 2 2
R. Fry, M. Sayaman, Dickinson, J Pringle, M. Abercrombie, P. Medawar, G. Salt, M. Swann, V. Wigglesworth, M Mayer, K. Vogtmann, B. Bausenwein, R. Wolf, M. Heisenberg, S. Swartz, K. Breuer, Grzegorz Kudla, A. Murray, D. Tollervey, J. Plotkin
References and Notes Supporting Online Material Coding-sequence Determinants of Gene Expression in Escherichia Coli
H. Gréen, P. Söderkvist, P. Rosenberg, G. Horvath, C. Peterson (2006)
mdr-1 Single Nucleotide Polymorphisms in Ovarian Cancer Tissue: G2677T/A Correlates with Response to Paclitaxel ChemotherapyClinical Cancer Research, 12
Minzhi Li, Jinjing Tan, Xiaoqing Yang, Li Su, Juan-juan Xie, Bao-yun Liang, Jianxiong Long, Haiyun Jiang, Qiugui Wei, Tingting Shen, Qing Chen, Yan Yan, Guangliang Wu, Lian Gu (2014)
The ABCB1-C3435T polymorphism likely acts as a risk factor for resistance to antiepileptic drugsEpilepsy Research, 108
C. Kiyohara, Y. Miyake, Midori Koyanagi, T. Fujimoto, S. Shirasawa, Keiko Tanaka, W. Fukushima, S. Sasaki, Y. Tsuboi, Tatsuo Yamada, T. Oeda, H. Shimada, N. Kawamura, N. Sakae, H. Fukuyama, Y. Hirota, M. Nagai (2013)
MDR1 C3435T polymorphism and interaction with environmental factors in risk of Parkinson's disease: a case-control study in Japan.Drug metabolism and pharmacokinetics, 28 2
Q. Zheng, H. Wu, Q. Yu, D. Kim, J. Lipton, Sabrina Angelini, S. Soverini, D. Vivona, Naoto Takahashi, J. Cao (2014)
ABCB1 polymorphisms predict imatinib response in chronic myeloid leukemia patients: a systematic review and meta-analysisThe Pharmacogenomics Journal, 15
T. Furuno, M. Landi, M. Ceroni, N. Caporaso, I. Bernucci, G. Nappi, E. Martignoni, E. Schaeffeler, M. Eichelbaum, M. Schwab, U. Zanger (2002)
Expression polymorphism of the blood-brain barrier component P-glycoprotein (MDR1) in relation to Parkinson's disease.Pharmacogenetics, 12 7
T. Loo, M. Bartlett, D. Clarke (2006)
Transmembrane segment 7 of human P-glycoprotein forms part of the drug-binding pocket.The Biochemical journal, 399 2
E. Woodahl, Ziping Yang, T. Bui, D. Shen, R. Ho (2004)
Multidrug Resistance Gene G1199A Polymorphism Alters Efflux Transport Activity of P-GlycoproteinJournal of Pharmacology and Experimental Therapeutics, 310
Shin-ichi Akiyama, A. Fojo, J. Hanover, I. Pastan, M. Gottesman (1985)
Isolation and genetic characterization of human KB cell lines resistant to multiple drugsSomatic Cell and Molecular Genetics, 11
L. Oostenbrug, G. Dijkstra, I. Nolte, H. Dullemen, E. Oosterom, K. Faber, D. Jong, K. Linde, G. Meerman, G. Steege, J. Kleibeuker, P. Jansen (2006)
Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel diseaseScandinavian Journal of Gastroenterology, 41
C. Higgins (1992)
ABC transporters: from microorganisms to man.Annual review of cell biology, 8
Yi Li, Xin Hu, B. Cai, Jie Chen, Yang-juan Bai, Jiangtao Tang, Y. Liao, Lanlan Wang (2012)
Meta-analysis of the effect of MDR1 C3435 polymorphism on tacrolimus pharmacokinetics in renal transplant recipients.Transplant immunology, 27 1
L. Mickley, Jong-Seok Lee, Zheng Weng, Z. Zhan, Manuel Alvarez, Wyndham Wilson, Susan Bates, T. Fojo (1998)
Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.Blood, 91 5
Joanna Parmley, L. Hurst (2007)
Exonic splicing regulatory elements skew synonymous codon usage near intron-exon boundaries in mammals.Molecular biology and evolution, 24 8
U. Stein, W. Walther, V. Wunderlich (1994)
Point mutations in the mdr1 promoter of human osteosarcomas are associated with in vitro responsiveness to multidrug resistance relevant drugs.European journal of cancer, 30A 10
J. Smit, A. Schinkel, B. Weert, D. Meijer (1998)
Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice in which both mdr1a and mdr1b genes have been disruptedBritish Journal of Pharmacology, 124
A. Saitoh, K. Singh, C. Powell, Terrence Fenton, C. Fletcher, R. Brundage, S. Starr, S. Spector (2005)
An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected childrenAIDS, 19
S. Johnatty, J. Beesley, B. Gao, Xiaoqing Chen, Yi Lu, M. Law, M. Henderson, A. Russell, E. Hedditch, C. Emmanuel, S. Fereday, P. Webb, E. Goode, R. Vierkant, B. Fridley, J. Cunningham, P. Fasching, M. Beckmann, A. Ekici, E. Høgdall, S. Kjaer, A. Jensen, C. Høgdall, Robert Brown, J. Paul, S. Lambrechts, E. Despierre, I. Vergote, J. Lester, B. Karlan, F. Heitz, A. Bois, P. Harter, I. Schwaab, Yukie Bean, T. Pejovic, D. Levine, M. Goodman, Michael Camey, P. Thompson, G. Lurie, Joellen Shildkraut, A. Berchuck, K. Terry, D. Cramer, M. Norris, M. Haber, S. Macgregor, A. deFazio, G. Chenevix-Trench (2013)
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas.Gynecologic oncology, 131 1
O. Levran, K. O'Hara, E. Peles, Dawei Li, S. Barral, B. Ray, L. Borg, J. Ott, M. Adelson, M. Kreek (2008)
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence.Human molecular genetics, 17 14
Rachel Engen, Sharon Marsh, D. Booven, H. McLeod, H. McLeod (2006)
Ethnic differences in pharmacogenetically relevant genes.Current drug targets, 7 12
G. Ho, N. Soranzo, E. Nimmo, A. Tenesa, D. Goldstein, J. Satsangi (2006)
ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach.Human molecular genetics, 15 5
Joanna Parmley, J. Chamary, L. Hurst (2006)
Evidence for purifying selection against synonymous mutations in mammalian exonic splicing enhancers.Molecular biology and evolution, 23 2
M. Dean, Y. Hamon, G. Chimini (2001)
The human ATP-binding cassette (ABC) transporter superfamily.Journal of lipid research, 42 7
J. Hubacek (2014)
Drug metabolising enzyme polymorphisms in Middle- and Eastern-European Slavic populations, 29
I. Sugawara, Iyo Kataoka, Y. Morishita, H. Hamada, T. Tsuruo, S. Itoyama, S. Mori (1988)
Tissue distribution of P-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16.Cancer research, 48 7
Nancy Richert, L. Aldwin, D. Nitecki, M. Gottesman, I. Pastan (1988)
Stability and covalent modification of P-glycoprotein in multidrug-resistant KB cells.Biochemistry, 27 20
E. Chufán, K. Kapoor, Hong‐May Sim, Satyakam Singh, T. Talele, S. Durell, S. Ambudkar (2013)
Multiple Transport-Active Binding Sites Are Available for a Single Substrate on Human P-Glycoprotein (ABCB1)PLoS ONE, 8
S. Ozawa, A. Soyama, M. Saeki, Hiromi Fukushima-Uesaka, M. Itoda, Satoru Koyano, K. Sai, Y. Ohno, Yoshiro Saito, J. Sawada (2004)
Ethnic differences in genetic polymorphisms of CYP2D6, CYP2C19, CYP3As and MDR1/ABCB1.Drug metabolism and pharmacokinetics, 19 2
Yuji Yamakawa, Akinobu Hamada, Reiko Nakashima, Misato Yuki, Chie Hirayama, Tatsuya Kawaguchi, Hideyuki Saito (2011)
Association of Genetic Polymorphisms in the Influx Transporter SLCO1B3 and the Efflux Transporter ABCB1 With Imatinib Pharmacokinetics in Patients With Chronic Myeloid LeukemiaTherapeutic Drug Monitoring, 33
J. Riordan, K. Deuchars, N. Kartner, N. Alon, J. Trent, V. Ling (1985)
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell linesNature, 316
Ji-Wei Cheng, Lijun Zhang, Yuqing Hou, Qing Zhao, Xiao-jing Zhang, Xuefen Chen, Yu Bai (2014)
Association between MDR1 C3435T polymorphism and refractory epilepsy in the Chinese population: A systematic review and meta-analysisEpilepsy & Behavior, 36
A. Pétain, D. Kattygnarath, J. Azard, E. Chatelut, C. Delbaldo, B. Geoerger, M. Barrois, S. Séronie-Vivien, A. Lecesne, G. Vassal (2008)
Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and AdultsClinical Cancer Research, 14
I. Ieiri (2012)
Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2).Drug metabolism and pharmacokinetics, 27 1
Caroline Lee, M. Gottesman, C. Cardarelli, M. Ramachandra, K. Jeang, S. Ambudkar, I. Pastan, S. Dey (1998)
HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.Biochemistry, 37 11
E. Gardner, H. Burger, R. Schaik, A. Oosterom, E. Bruijn, G. Guetens, H. Prenen, F. Jong, S. Baker, S. Bates, W. Figg, J. Verweij, A. Sparreboom, K. Nooter (2006)
Association of enzyme and transporter genotypes with the pharmacokinetics of imatinibClinical Pharmacology & Therapeutics, 80
Weirong Yao, Rongzeng Yan, Lin Ma, Huiping Wan, Yanmin Yu, Xiao Cheng, Yingliang Li (2014)
CD243 gene polymorphism significantly associated with breast cancer susceptibilityTumor Biology, 35
S. Ambudkar, In-Wha Kim, D. Xia, Z. Sauna (2006)
The A‐loop, a novel conserved aromatic acid subdomain upstream of the Walker A motif in ABC transporters, is critical for ATP bindingFEBS Letters, 580
R. Kim, B. Leake, E. Choo, G. Dresser, Samir Kubba, U. Schwarz, A. Taylor, H. Xie, J. McKinsey, Sheng Zhou, Lu-bin Lan, J. Schuetz, E. Schuetz, G. Wilkinson (2001)
Identification of functionally variant MDR1 alleles among European Americans and African AmericansClinical Pharmacology & Therapeutics, 70
S. Johnatty, J. Beesley, J. Paul, S. Fereday, A. Spurdle, P. Webb, K. Byth, S. Marsh, H. McLeod, P. Harnett, Robert Brown, A. deFazio, G. Chenevix-Trench (2008)
ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin ChemotherapyClinical Cancer Research, 14
J. Coller, D. Barratt, K. Dahlen, Morten Loennechen, A. Somogyi (2006)
ABCB1 genetic variability and methadone dosage requirements in opioid‐dependent individualsClinical Pharmacology & Therapeutics, 80
I. Roninson, J. Chin, K. Choi, Philippe GROSt, David HOUSMANt, Antonio Fojot, DING-WU SHENt, Michael GOTTESMANt, Ira PASTANt (1986)
Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.Proceedings of the National Academy of Sciences of the United States of America, 83 12
M. Fromm (2004)
Importance of P-glycoprotein at blood-tissue barriers.Trends in pharmacological sciences, 25 8
A. Schinkel, U. Mayer, E. Wagenaar, C. Mol, L. Deemter, J. Smit, M. Valk, A. Voordouw, H. Spits, O. Tellingen, J. Zijlmans, W. Fibbe, P. Borst (1997)
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.Proceedings of the National Academy of Sciences of the United States of America, 94 8
S. Ross, G. Paré (2013)
Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran.Pharmacogenomics, 14 13
B. Dennis, M. Bawor, L. Thabane, Z. Sohani, Z. Samaan (2014)
Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-AnalysisPLoS ONE, 9
Abdel-Hameed Ebid, M. Ahmed, S. Mohammed (2007)
Therapeutic Drug Monitoring and Clinical Outcomes in Epileptic Egyptian Patients: A Gene Polymorphism Perspective StudyTherapeutic Drug Monitoring, 29
E Piddini, F. Marshall, L. Dubois, E. Hirst, J.-P Vincent, J Lippincott-Schwartz, N. Altan-Bonnet, G. Patterson, D. Axelrod, D. Koppel, J. Schlessinger, E. Elson, W. Webb, Biophys, G. Baeg, E. Selva, R. Goodman, R. Dasgupta, C Han, D. Yan, T. Belenkaya, X. Lin, A Rives, K. Rochlin, M. Wehrli, S. Schwartz, C. Kimchi-Sarfaty, C Jung, Mi Oh, In-Wha Kim, Z. Sauna, A. Calcagno, S. Ambudkar, Michael Gottesman
Supporting Online Material Materials and Methods Som Text Figs. S1 to S8 Table S1 Movies S1 to S3 a " Silent " Polymorphism in the Mdr1 Gene Changes Substrate Specificity Corrected 30 November 2007; See Last Page
C. Skarke, Marwan Jarrar, H. Schmidt, G. Kauert, M. Langer, G. Geisslinger, J. Lötsch (2003)
Effects of ABCB1 (multidrug resistance transporter) gene mutations on disposition and central nervous effects of loperamide in healthy volunteers.Pharmacogenetics, 13 11
S. Hoffmeyer, O. Burk, O. Richter, H. Arnold, J. Brockmöller, A. Johne, I. Cascorbi, T. Gerloff, I. Roots, M. Eichelbaum, U. Brinkmann (2000)
Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.Proceedings of the National Academy of Sciences of the United States of America, 97 7
M. Gottesman, I. Pastan, S. Ambudkar (1996)
P-glycoprotein and multidrug resistance.Current opinion in genetics & development, 6 5
M. Gottesman, I. Pastan (1993)
Biochemistry of multidrug resistance mediated by the multidrug transporter.Annual review of biochemistry, 62
M. Horinouchi, T. Sakaeda, Tsutomu Nakamura, Y. Morita, T. Tamura, N. Aoyama, M. Kasuga, K. Okumura (2002)
Significant Genetic Linkage of MDR1 Polymorphisms at Positions 3435 and 2677: Functional Relevance to Pharmacokinetics of DigoxinPharmaceutical Research, 19
N. Kioka, J. Tsubota, Y. Kakehi, T. Komano, M. Gottesman, I. Pastan, K. Ueda (1989)
P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.Biochemical and biophysical research communications, 162 1
T. Loo, M. Bartlett, D. Clarke (2002)
The “LSGGQ” Motif in Each Nucleotide-binding Domain of Human P-glycoprotein Is Adjacent to the Opposing Walker A Sequence*The Journal of Biological Chemistry, 277
Vladimir Presnyak, Najwa Alhusaini, Ying-Hsin Chen, Sophie Martin, N. Morris, Nicholas Kline, S. Olson, D. Weinberg, K. Baker, B. Graveley, Jeff Coller (2015)
Codon Optimality Is a Major Determinant of mRNA StabilityCell, 160
Jun Wang, Xufeng Guo, Shijie Yu, Jixiang Zhang, Jia Song, Mengyao Ji, Zhuo Cao, Jing Wang, Ya Liu, W. Dong (2014)
MDR1 C3435T polymorphism and inflammatory bowel disease risk: a meta-analysisMolecular Biology Reports, 41
Yukihiko Nakamura, S. Ikeda, T. Furukawa, T. Sumizawa, A. Tani, Shin-ichi Akiyama, Yukihiro Nagata (1997)
Function of P-glycoprotein expressed in placenta and mole.Biochemical and biophysical research communications, 235 3
X. Sheng, Limei Zhang, N. Tong, D. Luo, Meilin Wang, Min Xu, Zhengdong Zhang (2012)
MDR1 C3435T polymorphism and cancer risk: a meta-analysis based on 39 case–control studiesMolecular Biology Reports, 39
N. Kartner, M. Shales, J. Riordan, V. Ling (1983)
Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein.Cancer research, 43 9
I. Cascorbi, S. Haenisch (2010)
Pharmacogenetics of ATP-binding cassette transporters and clinical implications.Methods in molecular biology, 596
A. Paolo, Marialuisa Polillo, M. Capecchi, G. Cervetti, C. Baratè, S. Angelini, F. Guerrini, Giulia Fontanelli, R. Arici, E. Ciabatti, S. Grassi, G. Bocci, P. Hrelia, R. Danesi, M. Petrini, S. Galimberti (2014)
The c.480C>G polymorphism of hOCT1 influences imatinib clearance in patients affected by chronic myeloid leukemiaThe Pharmacogenomics Journal, 14
T. Loo, D. Clarke (1993)
Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.The Journal of biological chemistry, 268 5
Julien Marcoux, Sheila Wang, Argyris Politis, Eamonn Reading, Jerome Ma, P. Biggin, Min Zhou, Houchao Tao, Qinghai Zhang, G. Chang, N. Morgner, C. Robinson (2013)
Mass spectrometry reveals synergistic effects of nucleotides, lipids, and drugs binding to a multidrug resistance efflux pumpProceedings of the National Academy of Sciences, 110
Man Luo, Jiaoxing Li, Xiaowei Xu, Xunsha Sun, Wenli Sheng (2012)
ABCB1 C3435T polymorphism and risk of adverse clinical events in clopidogrel treated patients: a meta-analysis.Thrombosis research, 129 6
Hotcherl Jeong, I. Herskowitz, D. Kroetz, J. Rine (2007)
Function-Altering SNPs in the Human Multidrug Transporter Gene ABCB1 Identified Using a Saccharomyces-Based AssayPLoS Genetics, 3
J. Gribar, M. Ramachandra, C. Hrycyna, S. Dey, S. Ambudkar (2000)
Functional Characterization of Glycosylation-Deficient Human P-Glycoprotein Using A Vaccinia Virus Expression SystemThe Journal of Membrane Biology, 173
S. Horwitz, D. Cohen, Srinivasa Rao, Israel Ringel, Shen Hj, Yang Cp (1986)
Taxol: Mechanisms of Action and Resistance aAnnals of the New York Academy of Sciences, 466
K. Fung, M. Gottesman (2009)
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function.Biochimica et biophysica acta, 1794 5
Ji-hong Pan, Jin-Xiang Han, Jian-mei Wu, Hai-nan Huang, Qing-zhong Yu, Li-jun Sheng (2008)
MDR1 Single Nucleotide Polymorphism G2677T/A and Haplotype Are Correlated with Response to Docetaxel-Cisplatin Chemotherapy in Patients with Non-Small-Cell Lung CancerRespiration, 78
U. Germann, T. Chambers, S. Ambudkar, T. Licht, C. Cardarelli, I. Pastan, M. Gottesman (1996)
Characterization of Phosphorylation-defective Mutants of Human P-glycoprotein Expressed in Mammalian Cells (*)The Journal of Biological Chemistry, 271
J. Gartner, Stephen Parker, Todd Prickett, K. Dutton-Regester, M. Stitzel, Jimmy Lin, S. Davis, V. Simhadri, Sujata Jha, Nobuko Katagiri, Valer Gotea, J. Teer, Xiaomu Wei, M. Morken, U. Bhanot, Guo Chen, L. Elnitski, M. Davies, J. Gershenwald, H. Carter, R. Karchin, W. Robinson, S. Robinson, S. Rosenberg, F. Collins, G. Parmigiani, A. Komar, C. Kimchi-Sarfaty, N. Hayward, E. Margulies, Yardena Samuels (2013)
Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanomaProceedings of the National Academy of Sciences, 110
Jingzhi Li, K. Jaimes, S. Aller (2013)
Refined structures of mouse P-glycoproteinProtein Science : A Publication of the Protein Society, 23
K. Dittmar, J. Goodenbour, T. Pan (2006)
Tissue-Specific Differences in Human Transfer RNA ExpressionPLoS Genetics, 2
P. Brest, Pierre Lapaquette, Mouloud Souidi, K. Lebrigand, Annabelle Cesaro, V. Vouret-Craviari, B. Mari, P. Barbry, J. Mosnier, X. Hébuterne, A. Harel-Bellan, B. Mograbi, A. Darfeuille‐Michaud, P. Hofman (2011)
A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's diseaseNature Genetics, 43
W. Lv, R-F Han, Z. Shu (2014)
Associations between the C3435T polymorphism of the ABCB1 gene and drug resistance in epilepsy: a meta-analysis.International journal of clinical and experimental medicine, 7 11
Shen Dw, A. Fojo, J. Chin, I. Roninson, N. Richert, I. Pastan, M. Gottesman (1986)
Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.Science, 232 4750
Stephen Moran, J. Flanagan, O. Namy, D. Stuart, I. Brierley, R. Gilbert (2008)
The Mechanics of Translocation: A Molecular “Spring-and-Ratchet” SystemStructure (London, England : 1993), 16
P. Hafkemeyer, S. Dey, S. Ambudkar, C. Hrycyna, I. Pastan, M. Gottesman (1998)
Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein.Biochemistry, 37 46
S. Hamdy, M. Hiratsuka, K. Narahara, Naomi Endo, Mervat El-Enany, Nadia Moursi, M. Ahmed, M. Mizugaki (2003)
Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.British journal of clinical pharmacology, 55 6
J. Megías-Vericat, L. Rojas, L. Rojas, M. Herrero, M. Herrero, V. Bosó, Pau Montesinos, F. Moscardó, J. Poveda, M. Sanz, S. Aliño, S. Aliño (2015)
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studiesThe Pharmacogenomics Journal, 15
D. Kroetz, C. Pauli-Magnus, L. Hodges, Conrad Huang, M. Kawamoto, S. Johns, D. Stryke, T. Ferrin, J. Deyoung, T. Taylor, E. Carlson, I. Herskowitz, K. Giacomini, A. Clark (2003)
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene.Pharmacogenetics, 13 8
D. Macaya, D. Macaya, Sara Katsanis, Timothy Hefferon, S. Audlin, N. Mendelsohn, J. Roggenbuck, Garry Cutting (2009)
A synonymous mutation in TCOF1 causes Treacher Collins syndrome due to mis‐splicing of a constitutive exonAmerican Journal of Medical Genetics Part A, 149A
S. Aller, Jodie Yu, A. Ward, Yue Weng, S. Chittaboina, R. Zhuo, P. Harrell, Yenphuong Trinh, Qinghai Zhang, I. Urbatsch, G. Chang (2009)
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug BindingScience, 323
A. Fojo, K. Ueda, D. Slamon, D. Poplack, M. Gottesman, I. Pastan (1987)
Expression of a multidrug-resistance gene in human tumors and tissues.Proceedings of the National Academy of Sciences of the United States of America, 84 1
B. Chowbay, S. Cumaraswamy, Y. Cheung, Q. Zhou, Edmund Lee (2003)
Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients.Pharmacogenetics, 13 2
S. Shukla, Z. Sauna, S. Ambudkar (2008)
Evidence for the interaction of imatinib at the transport-substrate site(s) of the multidrug-resistance-linked ABC drug transporters ABCB1 (P-glycoprotein) and ABCG2Leukemia, 22
Kristin White, R. Vierkant, Z. Fogarty, Bridget Charbonneau, M. Block, P. Pharoah, G. Chenevix-Trench, M. Rossing, D. Cramer, C. Pearce, J. Schildkraut, U. Menon, S. Kjaer, D. Levine, J. Gronwald, H. Culver, A. Whittemore, B. Karlan, D. Lambrechts, N. Wentzensen, J. Kupryjańczyk, J. Chang-Claude, E. Bandera, E. Høgdall, F. Heitz, S. Kaye, P. Fasching, I. Campbell, M. Goodman, T. Pejovic, Yukie Bean, G. Lurie, D. Eccles, A. Hein, M. Beckmann, A. Ekici, J. Paul, Robert Brown, J. Flanagan, P. Harter, A. Bois, I. Schwaab, C. Høgdall, L. Lundvall, S. Olson, I. Orlow, L. Paddock, A. Rudolph, U. Eilber, A. Dansonka-Mieszkowska, I. Rzepecka, I. Ziółkowska-Seta, L. Brinton, Hannah Yang, M. García-Closas, E. Despierre, S. Lambrechts, I. Vergote, C. Walsh, J. Lester, W. Sieh, V. McGuire, J. Rothstein, A. Ziogas, J. Lubiński, C. Cybulski, J. Menkiszak, A. Jensen, S. Gayther, S. Ramus, A. Gentry-Maharaj, A. Berchuck, A. Wu, M. Pike, David Denberg, K. Terry, A. Vitonis, J. Doherty, S. Johnatty, A. deFazio, Honglin Song, J. Tyrer, T. Sellers, C. Phelan, K. Kalli, J. Cunningham, B. Fridley, E. Goode (2013)
Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer OutcomeCancer Epidemiology, Biomarkers & Prevention, 22
C. Lee, K. Tang, Y. Cheung, L. Wong, C. Tan, H. Shen, Y. Zhao, R. Pavanni, E. Lee, M. Wong, S. Chong, E. Tan (2004)
MDR1, the blood–brain barrier transporter, is associated with Parkinson’s disease in ethnic ChineseJournal of Medical Genetics, 41
A. Schinkel, E. Wagenaar, L. Deemter, C. Mol, P. Borst (1995)
Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.The Journal of clinical investigation, 96 4
Qi Wang, Yuanzhe Jin, Shao-bo Zhou, Li-jie Wang, Mingming Lei, Yong Wang, C. Miao (2014)
ABCB1 C3435T polymorphism and the risk of ischemic heart disease: a meta-analysis.Genetic testing and molecular biomarkers, 18 9
C. Sipeky, V. Csongei, L. Járomi, E. Sáfrány, A. Maász, I. Takács, J. Béres, L. Fodor, M. Szabó, B. Melegh (2011)
Genetic variability and haplotype profile of MDR1 (ABCB1) in Roma and Hungarian population samples with a review of the literature.Drug metabolism and pharmacokinetics, 26 2
Li Zhao, Kai Li, Wusheng Li, Zhen Yang (2013)
Association between the C3435T polymorphism of ABCB1/MDR1 gene (rs1045642) and colorectal cancer susceptibilityTumor Biology, 34
M. Notarangelo, F. Bontardelli, P. Merlini (2013)
Genetic and nongenetic factors influencing the response to clopidogrelJournal of Cardiovascular Medicine, 14
K. Nielsen, Suzette Sørensen, L. Cartegni, T. Corydon, T. Doktor, L. Schroeder, L. Reinert, O. Elpeleg, A. Krainer, N. Gregersen, J. Kjems, B. Andresen (2007)
Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer.American journal of human genetics, 80 3
K. Fung, James Pan, S. Ohnuma, P. Lund, Jessica Pixley, C. Kimchi-Sarfaty, S. Ambudkar, M. Gottesman (2014)
MDR1 synonymous polymorphisms alter transporter specificity and protein stability in a stable epithelial monolayer.Cancer research, 74 2
P. Mylona, J. Glazier, S. Greenwood, M. Sides, C. Sibley (1996)
Expression of the cystic fibrosis (CF) and multidrug resistance (MDR1) genes during development and differentiation in the human placenta.Molecular human reproduction, 2 9
M. Horio, K. Chin, S. Currier, S. Goldenberg, Carol Williams, I. Pastan, M. Gottesman, J. Handler (1989)
Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.The Journal of biological chemistry, 264 25
Kyunghee Choi, Chang-jie Chen, M. Kriegler, I. Roninson (1988)
An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) geneCell, 53
E. Woodahl, Ziping Yang, T. Bui, D. Shen, R. Ho (2005)
MDR1 G1199A polymorphism alters permeability of HIV protease inhibitors across P-glycoprotein-expressing epithelial cellsAIDS, 19
J. Gow, L. Hodges, L. Chinn, D. Kroetz (2008)
Substrate-Dependent Effects of Human ABCB1 Coding PolymorphismsJournal of Pharmacology and Experimental Therapeutics, 325
Mizuho Tanabe, I. Ieiri, Naoki Nagata, Kazuko Inoue, S. Ito, Y. Kanamori, Masakuni Takahashi, Yasuo Kurata, J. Kigawa, S. Higuchi, N. Terakawa, K. Otsubo (2001)
Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.The Journal of pharmacology and experimental therapeutics, 297 3
F. Sharom (2011)
The P-glycoprotein multidrug transporter.Essays in biochemistry, 50 1
D. Anglicheau, C. Verstuyft, P. Laurent-Puig, L. Becquemont, M. Schlageter, B. Cassinat, P. Beaune, C. Legendre, E. Thervet (2003)
Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.Journal of the American Society of Nephrology : JASN, 14 7
C. Tian, C. Ambrosone, K. Darcy, T. Krivak, D. Armstrong, M. Bookman, W. Davis, Hua Zhao, K. Moysich, H. Gallion, J. Deloia (2012)
Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.Gynecologic oncology, 124 3
Renata Silva, Vânia Vilas-Boas, H. Carmo, R. Dinis-Oliveira, F. Carvalho, Maria Bastos, F. Remião (2015)
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy.Pharmacology & therapeutics, 149
J. Plotkin, Grzegorz Kudla (2011)
Synonymous but not the same: the causes and consequences of codon biasNature Reviews Genetics, 12
[ABCB1 is a polymorphic gene that encodes a full ABC transporter with drug-binding pockets and two nucleotide-binding ATPase domains. It was one of the first members of the ABC transporter superfamily to be identified in humans. Since the discovery of this gene nearly 40 years ago, many mutations and polymorphisms in the coding region have been shown to have functional significance. Common genetic variations in the form of single nucleotide polymorphisms (SNPs) of ABCB1 have been shown to have a role in disease susceptibility and drug response. In this chapter, we summarize our current understanding of common ABCB1 SNPs and their impact on protein folding, drug transport function, disease risk factors, and drug pharmacokinetics. Unfortunately, clinical studies on the association of drug effects and ABCB1 polymorphisms are often inconclusive. In the past few years, meta-analyses of ABCB1 polymorphism studies have been carried out in attempts to draw more consistent conclusions. Among ABCB1 SNPs, the synonymous C3435T polymorphic site is perhaps one of the best-known silent mutations in the field of pharmacogenomics. Our current understanding of the mechanism of the effect of this “silent” SNP is discussed here. Overall, research efforts in the past 15 years have laid important groundwork concerning the effect of ABCB1 variants that should lead to advances in precision medicine in the future.]
Published: Dec 17, 2015
Keywords: C3435T Polymorphism; Synonymous Codon; Synonymous Mutation; ABCB1 Polymorphism; ABCB1 Transporter
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.